Merkley Pushes for Stronger Generic Marketplace Following EpiPen Price Increase
Washington, DC—Oregon’s Senator Jeff Merkley today questioned a top official at the Food and Drug Administration (FDA) about the FDA’s role in the generic drug marketplace in light of the dramatic increase in the price of EpiPens this summer. At the hearing, Senator Merkley asked the FDA’s Director of the